Brain

Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products

The Company's Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under...

VidaCalm Claims Evaluated: Analyzing the Formula’s Ingredients, Side Effects Risk and User Complaints

A 2026 structured overview of VidaCalm's 18-ingredient hearing support formula, ingredient research context, safety considerations, and what consumers searching for...

Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage

Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions...

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care. SAN DIEGO, April 14, 2026...

error: Content is protected !!